Home Analyst Ratings Cimarex Energy Stock Gets Reiterated At KeyBanc. It's Still Overweight

Cimarex Energy [XEC] Stock Gets Reiterated At KeyBanc. It’s Still Overweight

KeyBanc maintained its Cimarex Energy [XEC] rating to the equivalent of Overweight but changed the price target to $$46.0 from $42, in a research note dated 2021-01-07. That figure represents around a 5.89% premium from where the company’s shares closed on Wednesday. Other analysts also revised their coverage, with Trust’ analysts downgrading the shares from “a Buy” rating to “a Hold” rating in a research note to investors issued in early December. Meanwhile, Raymond James had raised its rating on XEC to “an Outperform” from the earlier “Mkt perform”, in a research note produced for clients on October 21, 2020. In addition, there was an upgrade from Truist on October 13, 2020. The rater changed XEC from “a Hold” to “a Buy”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Cimarex Energy Co. [NYSE:XEC] a Good Buy Right Now?

It should be noted that XEC technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 88% Buy in the last week and compares with 100% Buy in the past month. Data from Cimarex Energy Co.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 1.22 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 1.48 million shares while the medium-term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 1.46 million shares.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


XEC Price Performance

On Wall Street, Cimarex Energy Co. [NYSE:XEC] finished Wednesday’s session up 4.62% at $43.45. The stock went up to $43.49 at the same session while its lowest single-day price was $41.4873. In the last five days, it saw a rise of about 17.02%, Cimarex Energy Co. shares gained by almost 15.84% since the beginning of the year. However, the share price has dropped to as low as -21.41% below its one year high. On 01/06/21, the company shares recorded $43.49, the highest single-day price it has got to in the last 52-weeks, and a 52-week low was seen on 01/04/21, the same year at $37.59. The company’s shares have declined by -21.19% in the past year. The 50-day SMA achieved is $34.80 while the 200-day SMA is $27.59. Volume dropped to 1.75 million from 1.86 million in the previous session.

XEC Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 42.13 level, and in case of violation of this particular level, it will cause more drop to 40.81 level. On the upper level, 44.81 is still the key resistance. The stock may increase to the subsequent resistance at 44.13. The Relative Strength Index (RSI) pinned on the 14-day chart is 70.96, implying an overbought technical stance while the MACD stands at 2.34, meaning price will increase in the next trading period. Percent R indicator moved to 0.58%, implying bullish price movement. Stochastic %K at 77.18% suggest selling the stock.

What is the short interest in Cimarex Energy Co.?

Short interest in the Cimarex Energy Co. stock has plunged, decreasing by -0.56 million shares to total 2.96 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 2.4 million, data from Yahoo Finance shows. The increase of 18.92% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 3.34% of the overall float for the stock.

Cimarex Energy Co.’s Biggest Shareholders: Who Owns Cimarex Energy Co. [XEC]?

Filings by The Vanguard Group, Inc. showed that the firm now holds a total of 10,002,051 shares or roughly 9.81% of the outstanding XEC shares. This means their shares have increased by 178,488 from the 10,002,051 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, BlackRock Fund Advisors updated stake is worth $281,963,040. Details in the latest 13F filings reveal that SSgA Funds Management, Inc. disposed off their -16.50% stake valued at $163,709,002 while Victory Capital Management, Inc. added theirs at $151,545,715. During the last quarter, SSgA Funds Management, Inc. liquidated -900,145 of its shares in Cimarex Energy Co. while Victory Capital Management, Inc. bought 138,065 shares. The Diamond Hill Capital Management,’s holdings currently number 3,085,949 shares at $134084484.05. According to the firm’s last 13F report, Dimensional Fund Advisors LP shares in the company at filing stood at 2,587,880 shares, roughly $93,034,286.

XEC Earnings Forecast For The Current Quarter

Cimarex Energy Co. [XEC] is expected to report weak earnings results for the quarter ending in Dec 2020. Consensus estimates give the company expected revenues of $401.54M and earnings per share of $0.61 for Dec 2020. Looking further ahead, the company is expected to report revenue of $453.34M at an EPS of $0.88 for Mar 2021. The estimates represent a downside of 21.30% and 312.63% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

XEC Earnings Estimates For The Current Year

For the financial year, Cimarex Energy Co. [NYSE:XEC] is expected to bring in revenue of $1.56B. The returns are nearly $-800.0 million lower than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 0.94, lower than that of FY19 by -$3.52. Estimates put this year’s earnings growth at -78.90%, 313.80% for the next, and at an annual 14.72% over the next 5-year period. As for sales, forecasts are for a decrease of -34.10% in the current fiscal year and a further 21.30% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

Why did Protagenic Therapeutics Inc. (PTIX) stock commence the new week with a negative trend?

Protagenic Therapeutics Inc. (PTIX) shares declined 13.82% in the pre-market on Monday, July 26, 2021, as of this writing. In after-hours on Friday, Protagenic...

Acorda Therapeutics Inc. (ACOR) stock plunged during pre-market. Here’s what you should know.

Acorda Therapeutics Inc. (ACOR) stock rose by 24.15% at the last close whereas the ACOR stock price fell by 9.30% in the pre-market trading...

Why Socket Mobile Inc. (SCKT) stock price faced negativity in the pre-market?

Socket Mobile Inc. (SCKT) shares declined 10.18% in pre-hours to $7.50 per share. On Friday, SCKT's stock gained 43.97% to close Friday's morning session...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam